A global pharmaceutical company Sinclair Pharma is proud to introduce to the Russian market an innovative portfolio of aesthetic products and technologies.
Sinclair Pharma, one of international leaders in aesthetic medicine, specializes in development and production of innovative products and technologies with focus on collagen stimulation. Established in 1971 the company secured a high reputation on the world market winning recognition among professionals all over the world due to effective, safe products of high quality as well as stable results of their use. Today the company directly operates in Western Europe, the USA, Great Britain, South Korea, UAE, Brazil and Mexico.
The innovative portfolio of Sinclair Pharma covers all fields of aesthetic medicine. It is constantly expanding since the company is focused on satisfying needs of aesthetic professionals and dermatologists offering them a full range of products for effective and safe performance. Besides, Sinclair Pharma has a well-developed system of physician training both for experienced and new physicians giving them opportunity for constant development and improvement of their skills.
In the nearest future Russia will discover Perfectha® , the range of Hyaluronic Acid dermal fillers that millions of patients and physicians have been choosing for over 10 years in more than 70 countries worldwide. “Made in France” out of the best quality raw materials Perfectha® fillers are designed to achieve immediate, safe and natural-looking results: wrinkles correction, overall harmonization of the face, facial contouring and volumisation, skin lifting, elasticity and radiance.
New arrivals on the Russian market will include Ellansé® (manufactured in the Netherlands) that together with immediate results – deep wrinkles and facial lines and folds correction, volume regeneration – help to stimulate personal mechanisms of the collagen production securing long-lasting results as well as enhancing skin quality.
Later on Sinclair Pharma will announce launch plans for Silhouette Soft® suture (manufactured in the USA).
All Sinclair Pharma products are manufactured following the highest standards, working only with raw materials that comply with highest international standards of safety. Each process from a formula development to a product package is subject to strict quality control. As a result, the client receives a new generation product of optimal quality characterized by the absence of impurities with high elasticity, plasticity and cohesivity.
Apart from a strong portfolio of differentiated products the key components of future success on the Russian market include a custom-tailored approach to professional trainings, effective cooperation with partners as well as a number of scientific and marketing activities including pro-active collaboration with scientific community and opinion leaders.
The exclusive distributor of Sinclair Pharma in Russia is ESTEMARKO company.